Physician profile
Benjamin Goodman
NPI 1518282797
$3,145.27
in general payments reported to CMS, 2019-2025
13 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $704 · 2020: $14.51 · 2022: $2,296 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $130.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elekta, INC. | $1,218.90 | 2019-2022 | |
| Siemens Medical Solutions USA, INC. | $1,181.64 | 2022 | |
| Raysearch Laboratories Ab (Publ) | $485.00 | 2019 | |
| Bioprotect Medical, INC. | $65.75 | 2025 | Bioprotect Balloon Implant System |
| Boston Scientific Corporation | $35.94 | 2025 | Spaceoar Vue System - 10ml |
| Novartis Pharmaceuticals Corporation | $32.34 | 2019 | |
| Amgen INC. | $28.53 | 2025 | Imdelltra (Amg757), Lumakras |
| Eisai INC. | $21.20 | 2019 | |
| Daiichi Sankyo INC. | $18.72 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.79 | 2019 | |
| Merck Sharp & Dohme LLC | $14.51 | 2020 | |
| Celgene Corporation | $14.35 | 2019 | |
| Qfix | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Goodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.